Gallium 68 Market Scope And Analysis

  • Report Code : TIPRE00029992
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Gallium-68 Market Scope, Growth, Size and Share by 2030

Buy Now

Gallium-68 Market Report Gallium-68 Market Size and Share Gallium-68 Market Scope and Analysis

Gallium-68 Market Report Scope

Report Attribute Details
Market size in 2022 US$ 782.36 Million
Market Size by 2030 US$ 1,070.34 Million
Global CAGR (2022 - 2030) 4.0%
Historical Data 2020-2022
Forecast period 2022-2030
Segments Covered By Application
  • Oncology
  • Neurology
  • Cardiology
By End User
  • Hospitals
  • Diagnostic and Imaging Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Novartis AG
  • Telix Pharmaceuticals US Inc
  • IRE ELiT SA
  • ITM Medical Isotopes GmbH
  • Eckert Ziegler Radiopharma GmbH
  • ARTMS Inc
  • IBA Radiopharma Solutions
  • Cardinal Health
  • Rosatom

    • Competitive Landscape and Key Companies:

    Novartis AG, Telix Pharmaceuticals (US) Inc, IRE-ELiT SA, ITM Medical Isotopes GmbH, Eckert & Ziegler Radiopharma GmbH, ARTMS Inc, IBA Radiopharma Solutions, Cardinal Health, Rosatom, and Evergreen Theragnostics Inc are among the prominent companies profiled in the gallium-68 market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide.